Bertolini, Federico
 Distribuzione geografica
Continente #
NA - Nord America 229
EU - Europa 195
AS - Asia 68
OC - Oceania 1
SA - Sud America 1
Totale 494
Nazione #
US - Stati Uniti d'America 227
IT - Italia 54
CN - Cina 45
IE - Irlanda 32
SE - Svezia 32
GB - Regno Unito 29
FR - Francia 22
VN - Vietnam 15
DE - Germania 8
FI - Finlandia 8
ES - Italia 5
CA - Canada 2
HU - Ungheria 2
IN - India 2
JP - Giappone 2
CL - Cile 1
GR - Grecia 1
LA - Repubblica Popolare Democratica del Laos 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TR - Turchia 1
TW - Taiwan 1
UA - Ucraina 1
Totale 494
Città #
Chandler 71
Dublin 31
Ashburn 26
Southend 25
New York 11
Beijing 10
Verona 10
Dong Ket 9
Lawrence 9
Princeton 9
Helsinki 8
Jacksonville 7
Wilmington 7
Rome 6
Sindelfingen 6
Redmond 5
Nanjing 4
Seattle 4
Aosta 3
Mungia 3
Eger 2
Guangzhou 2
Jiaxing 2
Jinan 2
San Donà di Piave 2
San Francisco 2
Shenyang 2
Stockholm 2
Taiyuan 2
Toronto 2
Vila-real 2
Washington 2
Zhengzhou 2
Ann Arbor 1
Athens 1
Atlanta 1
Bologna 1
Bovolone 1
Caserta 1
Chengdu 1
Chicago 1
Dearborn 1
Denver 1
Dongguan 1
Falkenstein 1
Florence 1
Fukuoka 1
Haikou 1
Houston 1
Islamabad 1
Kochi 1
Lower Hutt 1
Milan 1
Nanchang 1
Ningbo 1
Norwalk 1
Phoenix 1
Puxian 1
Redwood City 1
Santiago 1
Sesto San Giovanni 1
Taipei 1
Tokyo 1
Trento 1
Udine 1
Vientiane 1
Totale 323
Nome #
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 88
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 78
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 52
Reasons for initiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study 48
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants 46
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations 39
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 38
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 37
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) 31
Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review 19
COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence 16
Remote mental health care interventions during the COVID-19 pandemic: An umbrella review 15
Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study 13
Totale 520
Categoria #
all - tutte 2.523
article - articoli 2.523
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 1 1 0 0 2 2 1 1 3 4 2 1
2020/202160 1 1 5 2 7 8 2 2 2 3 10 17
2021/202284 10 8 0 11 12 1 5 8 2 0 8 19
2022/2023219 10 22 18 37 15 55 0 14 28 6 9 5
2023/2024121 3 8 9 23 21 29 10 8 2 8 0 0
Totale 520